❭ Research by medical division ❭ Medicine ❭ Department of Endocrinology, Morbid Obesity and Preventive Medicine ❭ Type 2 diabetes and metabolism

Type 2 diabetes and metabolism

Kåre BirkelandGroup leader
Kåre Birkeland
Group leader

Visit homepage at UiO

 

 

 

 

 
Scroll to top

Home Department of Endocrinology, Morbid Obesity and Preventive Medicine Type 2 diabetes and metabolism

  • Group members

Recent publications

Langberg NE, Jenssen TG, Hopp E, Haugen A, Åsberg A, Birkeland KI, Hartmann A, Dahle DO (2026)
A Randomized Controlled Trial to Evaluate Allopurinol vs Placebo on Left Ventricular Mass in Living Kidney Donors
Kidney360 (in press)
DOI 10.34067/KID.0000001313, PubMed 42545761

de Sousa ARS, Klemsdal TO, Ghiasvand R, Svendsen M, Birkeland KI, Sveen KA (2026)
Lifestyle modifications in individuals with blood pressure beyond treatment target despite pharmacological treatment: design and baseline characteristics of the MeDiPA randomised controlled trial
Blood Press, 35 (1), 2705014
DOI 10.1080/08037051.2026.2705014, PubMed 42471008

Kongerud IC, Midtvedt K, Solbu MD, Øvrehus MA, Eikrem Ø, Eide IA, Heldal K, Birkeland K, Åsberg A, Jenssen TG (2026)
Can sodium-glucose cotransporter 2 (SGLT2) inhibition preserve renal structure and function in de novo kidney transplant recipients? Protocol for a randomised, double-blind, placebo-controlled trial assessing the efficacy of dapagliflozin on kidney structure, function and safety in kidney transplant recipients in Norway-the DEAK study
BMJ Open, 16 (6), e117263
DOI 10.1136/bmjopen-2026-117263, PubMed 42315275

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)